| Version | Summary | Created by | Modification | Content Size | Created at | Operation |
|---|---|---|---|---|---|---|
| 1 | Yu Peng | -- | 165 | 2026-09-22 10:54:44 | | | |
| 2 | Catherine Yang | -13 word(s) | 152 | 2026-09-23 02:21:15 | | | | |
| 3 | Yu Peng | Meta information modification | 152 | 2026-09-23 05:21:01 | | |
Steroid biosynthesis is the set of enzyme-catalyzed metabolic pathways that generate sterols and their steroid-derived products from isoprenoid precursors. In the canonical eukaryotic pathway, acetyl-coenzyme A is converted through the mevalonate pathway into activated isoprene units, which are condensed to form squalene; squalene epoxidation and oxidosqualene cyclization then establish the tetracyclic sterol nucleus [1][2]. Subsequent reactions—including demethylation, reduction, oxidation, isomerization, side-chain modification, and hydroxylation—produce lineage-specific membrane sterols, such as cholesterol, phytosterols, or ergosterol, and, where present, downstream steroidal metabolites [2][3]. In animals, steroid biosynthesis also encompasses the conversion of cholesterol into steroid hormones through compartmentalized reactions involving cholesterol side-chain cleavage, hydroxylation, dehydrogenation, and related transformations catalyzed principally by cytochrome P450 enzymes and hydroxysteroid dehydrogenases [3]. The concept therefore includes both construction of the sterol scaffold from isoprenoid metabolism and its enzymatic diversification, but excludes ribosomally encoded peptide synthesis and non-isoprenoid pathways yielding structurally unrelated cyclic lipids.